









wwwClosure of a persistent esophagopleural ﬁstula by use of an
atrial septal occluder devicere 1. A, Abdominal CT scan conﬁrming the persistent esophagopleural ﬁstula (yellow arrow), an adequately placed stent (red arrow), and a right
al effusion (arrowhead). B, Esophagram showing contrast medium leaking into the right pleural space (yellow arrow). C, Upper endoscopy
ling a 5-mm ﬁstulous opening in the proximal esophagus (blue arrow). D, Side view of the chest wall demonstrating the thoracostomy window,
he subtle ﬁstulous opening (yellow arrow). E, Scheme of the atrial septal occluder device that was deployed under endoscopic guidance. Copyright
by W.L. Gore & Associates, Inc. Reprinted by permission of W.L. Gore & Associates, Inc. F, Endoscopic view of the esophagus, showing the proximal
of the deployed atrial occluder device covering the ﬁstulous opening. G, Side view of the chest wall showing the deployed atrial septal occluder
ring the ﬁstulous defect. H, 4-week follow-up CT scan of the abdomen, showing device and closed defect (green arrow). I, Side view of the chest
demonstrating the septal occluder covered by ﬁbrous connective tissue (yellow arrow).A 55-year-old man with a radiation-induced esophageal
stricture experienced an esophagopleural ﬁstula (EPF)
as an adverse event of endoscopic balloon dilation
therapy. Despite 9 months of covered esophageal stent
treatment, the ﬁstula persisted (Figs. 1A and B). Owing
to its recessed position and ﬁbrotic nature, endoclip
closure was unlikely to be beneﬁcial (Fig. 1C). The
patient underwent an Eloesser ﬂap thoracostomy, and 2en transcript of the video audio is available online at www.VideoGIE.org.
.VideoGIE.orgmonths later, an atrial septal occluder was deployed
(Fig. 1D; Video 1, available online at www.VideoGIE.org).
The cavernostomy wound was unpacked. Under
endoscopic guidance, an atrial septal occluder device was
passed through the ﬁstula and into the esophagus
(Fig. 1E). The proximal end of the occluder was
deployed and pulled against the esophageal wall. The
distal end was then deployed in a standard fashionVolume 1, No. 2 : 2016 VIDEOGIE 27
Video(Fig. 1F). Once the occluder was deployed, the distal end
was sutured to the chest wall in 2 locations with 4-0
Polysorb suture (Polysor, Covidien, Medtronic,
Minneapolis, Minn), to ensure anchoring and prevent
disruption with dressing changes (Fig. 1G). An initial
esophagogram performed 1 week after deployment
showed a persistent leak, but time was allowed to
achieve tissue ingrowth of the device, and at 4 weeks,
closure of the ﬁstula was conﬁrmed (Figs. 1H and I). An
atrial septal occluder device should be considered for
persistent EPFs that fail conventional therapy.
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